GLOUCESTER MARINE GENOMICS INSTITUTE INCORPORATED

GLOUCESTER MARINE GENOMICS INSTITUTE INCORPORATED specializes in marine genomic research and bioinformatics, applying advanced molecular biology techniques to study aquatic organisms and marine ecosystems. Their core capabilities include high-throughput DNA sequencing, transcriptomic and epigenomic analysis, bioinformatic pipeline development, and data interpretation for biodiversity and environmental monitoring. The firm leverages next-generation sequencing platforms and computational biology tools to generate actionable insights for marine conservation, fisheries management, and ecosystem health assessment. Their technical expertise lies in genome assembly, metagenomic profiling, and molecular marker development, with a focus on non-model marine species. Differentiators include their coastal laboratory infrastructure in Gloucester, enabling rapid sample processing and field-to-sequence workflows, and a research-driven approach grounded in marine biological science. Award history is not available to confirm specific agency engagements, so no definitive patterns of federal collaboration can be inferred. Similarly, without contract data, the primary federal customers or programmatic focus areas cannot be identified. The company operates under NAICS 541714, which encompasses research and development in the biological sciences, specifically focusing on life sciences research rather than applied engineering or IT services. Their market positioning centers on academic, environmental, and potentially NOAA- or USGS-aligned marine science initiatives, though direct programmatic ties cannot be confirmed from available data. GLOUCESTER MARINE GENOMICS INSTITUTE INCORPORATED is a small, locally based entity headquartered in Gloucester, Massachusetts, with no publicly disclosed government certifications. The organization maintains a focused geographic footprint aligned with New England’s marine research ecosystem, positioning itself as a specialized research provider within the marine genomics niche. Its operational model emphasizes scientific rigor and field-integrated laboratory capabilities rather than large-scale federal contracting infrastructure.